Johns Hopkins Singapore International Medical Centre
About Johns Hopkins Singapore International Medical Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
7
National Cancer Institute (NCI)
5
Boehringer Ingelheim
3
Cancer Therapeutics Research Group
3
Puma Biotechnology, Inc.
3
Astellas Pharma Inc
2
Hoffmann-La Roche
2
Johns Hopkins University
2
National Cancer Centre, Singapore
2
Odonate Therapeutics, Inc.
2
Adherex Technologies, Inc.
1
Clinical Trials at Johns Hopkins Singapore International Medical Centre
During the past decade, Johns Hopkins Singapore International Medical Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 12 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
2003-06-01
2006-09-01
Completed
Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
2003-11-01
2011-02-01
Completed
50
3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer
2004-04-01
2008-02-01
Completed
31
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
2004-04-01
2006-09-01
Withdrawn
0
A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma
Terminated
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
2006-03-03
Active, not recruiting
18
Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma
Withdrawn
0
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Johns Hopkins Singapore International Medical Centre" #1 sponsor was "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 7 trials, followed by "National Cancer Institute (NCI)" with 5 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Cancer Therapeutics Research Group" with 3 trials sponsored and "Puma Biotechnology, Inc."
with 3 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Singapore International Medical Centre"
#1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "CIMAB (Cuba)" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Johns Hopkins Singapore International Medical Centre
According to Clinical.Site data, the most researched conditions in "Johns Hopkins Singapore International Medical Centre" are
"Breast Cancer" (8 trials), "Hepatocellular Carcinoma" (2 trials), "Lung Cancer" (2 trials), "NSCLC" (2 trials) and "Nasopharyngeal Carcinoma" (2 trials). Many other conditions were trialed in "Johns Hopkins Singapore International Medical Centre" in a lesser frequency.
Clinical Trials Intervention Types at Johns Hopkins Singapore International Medical Centre
Most popular intervention types in "Johns Hopkins Singapore International Medical Centre" are "Drug" (33 trials), "Other" (6 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine" (4 trials), "Laboratory Biomarker Analysis" (4 trials), "Placebo" (3 trials), "Doxorubicin" (2 trials) and "Erlotinib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Johns Hopkins Singapore International Medical Centre
The vast majority of trials in "Johns Hopkins Singapore International Medical Centre" are
30 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Johns Hopkins Singapore International Medical Centre
Currently, there are NaN active trials in "Johns Hopkins Singapore International Medical Centre".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Johns Hopkins Singapore International Medical Centre,
undefined suspended trials,
and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Johns Hopkins Singapore International Medical Centre, 6 "Phase 1"
clinical trials were conducted, 24 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Johns Hopkins Singapore International Medical Centre
Johns Hopkins Singapore International Medical Centre has several departments that took part in Clinical trials: "Puno Global Non-Communicable Disease Research Site, School of Medicine, Johns Hopkins University" - 2 trials
Departments List